Hughes; Thomas Edward

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hughes; Thomas Edward.The latest application filed is for "combinations comprising a dipeptidylpeptidase - iv inhibitor".

Company Profile

0.1.20

Hughes; Thomas Edward - Condord MA
Hughes; Thomas Edward - Concord MA
Hughes, Thomas Edward - Somerville NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combinations Comprising A Dipeptidylpeptidase - Iv Inhibitor App 20140142145 - Balkan; Bork ; et al.	2014-05-22
Use Of A Dpp-iv Inhibitor To Reduce Hypoglycemic Events App 20120149639 - Balkan; Bork ; et al.	2012-06-14
Combination Of Dpp-iv Inhibitor, Ppar Antidiabetic And Metmorformin App 20110301172 - Burkey; Bryan ; et al.	2011-12-08
Use Of Organic Compounds App 20110245317 - HUGHES; Thomas Edward	2011-10-06
Use of organic compounds Grant 7,935,723 - Hughes May 3, 2	2011-05-03
Vildagliptin For Treating General Peripheral Neuropathies App 20100160408 - Hughes; Thomas Edward	2010-06-24
Method Of Treatment App 20100016387 - Bose; Avirup ; et al.	2010-01-21
Combination Of Dpp-iv Inhibitor, Ppar Antidiabetic And Metmorfin App 20090253752 - Burkey; Bryan ; et al.	2009-10-08
Dpp-iv inhibitors for treating neurodegeneration and cognitive disorders App 20090017015 - Hughes; Thomas Edward	2009-01-15
Use of Dpp-IV Inhibitor to Reduce Hypoglycemic Events App 20080300171 - Balkan; Bork ; et al.	2008-12-04
Combination of Organic Compounds App 20080221200 - Allison; Malcolm ; et al.	2008-09-11
Combinations Comprising Depeptidypeptidase-iv Inhibitors And Antidiabetic Agents App 20080076811 - Balkan; Bork ; et al.	2008-03-27
Combination of a DPP IV inhibitor and a cardiovascular compound App 20070293474 - Holmes; David Grenville ; et al.	2007-12-20
Use of Organic Compounds App 20070254944 - Hughes; Thomas Edward	2007-11-01
Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers App 20070027197 - Damon; Robert Edson ; et al.	2007-02-01
Combination of dpp iv inhibitor and a cardiovascular compound App 20060074058 - Holmes; David Grenville ; et al.	2006-04-06
Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases App 20050176806 - Holmes, David Grenville ; et al.	2005-08-11
Methods to treat diabetes and related conditions based on polymorphisms in the tcf-1 gene App 20050042614 - Hughes, Thomas Edward ; et al.	2005-02-24
Combination of organic compounds App 20040002519 - Damon, Robert Edson ; et al.	2004-01-01
Combinations comprising dipeptidylpeptidase-iv inhibitor App 20030139434 - Balkan, Bork ; et al.	2003-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.